156 related articles for article (PubMed ID: 9440134)
1. Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.
Nemoto K; Pilbeam CC; Bilak SR; Raisz LG
Prostaglandins; 1997 Oct; 54(4):713-25. PubMed ID: 9440134
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.
Castleberry TA; Lu B; Smock SL; Owen TA
Prostaglandins Other Lipid Mediat; 2001 Jul; 65(4):167-87. PubMed ID: 11444589
[TBL] [Abstract][Full Text] [Related]
3. Cloning and expression of the rabbit prostaglandin EP2 receptor.
Guan Y; Stillman BA; Zhang Y; Schneider A; Saito O; Davis LS; Redha R; Breyer RM; Breyer MD
BMC Pharmacol; 2002 Jun; 2():14. PubMed ID: 12097143
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW
Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
Honda A; Sugimoto Y; Namba T; Watabe A; Irie A; Negishi M; Narumiya S; Ichikawa A
J Biol Chem; 1993 Apr; 268(11):7759-62. PubMed ID: 8385118
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of the canine prostaglandin E receptor EP2 subtype.
Hibbs TA; Lu B; Smock SL; Vestergaard P; Pan LC; Owen TA
Prostaglandins Other Lipid Mediat; 1999 May; 57(2-3):133-47. PubMed ID: 10410384
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2.
An S; Yang J; Xia M; Goetzl EJ
Biochem Biophys Res Commun; 1993 Nov; 197(1):263-70. PubMed ID: 8250933
[TBL] [Abstract][Full Text] [Related]
8. Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.
Bastien L; Sawyer N; Grygorczyk R; Metters KM; Adam M
J Biol Chem; 1994 Apr; 269(16):11873-7. PubMed ID: 8163486
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype.
Sando T; Usui T; Tanaka I; Mori K; Sasaki Y; Fukuda Y; Namba T; Sugimoto Y; Ichikawa A; Narumiya S
Biochem Biophys Res Commun; 1994 May; 200(3):1329-33. PubMed ID: 8185583
[TBL] [Abstract][Full Text] [Related]
10. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.
Sugimoto Y; Namba T; Honda A; Hayashi Y; Negishi M; Ichikawa A; Narumiya S
J Biol Chem; 1992 Apr; 267(10):6463-6. PubMed ID: 1372606
[TBL] [Abstract][Full Text] [Related]
12. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts.
Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P
J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons.
Takadera T; Ohyashiki T
Life Sci; 2006 Mar; 78(16):1878-83. PubMed ID: 16309709
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor.
Woodward DF; Bogardus AM; Donello JE; Fairbairn CE; Gil DW; Kedzie KM; Burke JA; Kharlamb A; Runde E; Andrews SW
J Ocul Pharmacol Ther; 1995; 11(3):447-54. PubMed ID: 8590276
[TBL] [Abstract][Full Text] [Related]
15. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
18. Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.
Zeng L; An S; Goetzl EJ
Immunology; 1995 Dec; 86(4):620-8. PubMed ID: 8567030
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development.
Kasugai S; Oida S; Iimura T; Arai N; Takeda K; Ohya K; Sasaki S
Bone; 1995 Jul; 17(1):1-4. PubMed ID: 7577151
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
